- Home
- Clinical Trials
Hypertension Studies Auckland
Holly Hypertension Study Auckland
Auckland
Momentum Clinical Research is conducting a research study for adults aged 18 to 65 with high blood pressure (Hypertension). This is the second phase of a first-in-human study. The study will evaluate the safety of an investigational study medicine, how well it is tolerated and how it acts in the body.
Description
What to expect
Study details
Ages
18-65
Duration
Participation lasts approximately 10 weeks, including screening, treatment and follow-up. This includes approximately 7 clinic visits, including one 5-night and one 4-night inpatient stay at our clinical research facility.
Compensation
Participants will receive up to $8,100
Eligibility Criteria
You may be eligible if you:
- Are aged 18 to 65 years
- Have high blood pressure that is untreated or managed with no more than two blood pressure medicines
- May be able to stop current blood pressure medicines for the required study period under study-team supervision
- Have a BMI between 18-32 and a minimum weight of 50kg
- Are willing and able to follow all study requirements, including contraception requirements as applicable
Other eligibility criteria apply. Our team will help assess whether this study is suitable for you.
Locations
Description
Hypertension or high blood pressure means the pressure of blood moving through the blood vessels stays higher than recommended. Left untreated, hypertension can result in excessive pressure on artery walls that restricts the flow of blood and oxygen to the heart. This can increase the risk of chest pain and serious cardiovascular events.
This study aims to evaluate an investigational study medicine for hypertension. Researchers want to learn about its safety, how well it is tolerated, how the body processes it and its effects on the body, including blood pressure. The medicine has not been proven to treat high blood pressure.
What to expect
Participants on any current blood pressure medications will need to stop taking their medication for a period under the supervision of the study team.
The study will also involve:
- Four weekly injections of the investigational medicine or placebo
- Two inpatient stays and outpatient follow-up visits
- Blood and urine samples, heart tracing, physical examinations and regular blood pressure monitoring
- Your health and wellbeing will be closely monitored throughout the study by our experienced clinical research team.
All personal information will be kept strictly confidential.
Apply Now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. By clicking 'Submit' you agree to our Privacy Policy which contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.